These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 34082086

  • 1. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis.
    Peters TE, Kreuels B, Addo MM, Tannich E, Rothe C.
    Travel Med Infect Dis; 2021; 43():102090. PubMed ID: 34082086
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of patients with refractory giardiasis.
    Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA.
    Clin Infect Dis; 2001 Jul 01; 33(1):22-8. PubMed ID: 11389490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
    Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM.
    PLoS Negl Trop Dis; 2010 May 11; 4(5):e682. PubMed ID: 20485492
    [Abstract] [Full Text] [Related]

  • 11. Giardiasis: a pharmacotherapy review.
    Escobedo AA, Cimerman S.
    Expert Opin Pharmacother; 2007 Aug 11; 8(12):1885-902. PubMed ID: 17696791
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
    Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L.
    J Antimicrob Chemother; 2000 Nov 11; 46(5):819-21. PubMed ID: 11062206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A, Schunk M, Theunissen C, Van Esbroeck M, Mechain M, Hatz C, Mørch K, Soriano Pérez MJ, Sydow V, Sothmann P, Kuenzli E, Rothe C, Bottieau E.
    Clin Infect Dis; 2021 Oct 20; 73(8):1517-1523. PubMed ID: 34115100
    [Abstract] [Full Text] [Related]

  • 17. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
    Ribeiro MRS, Oliveira DR, Caliari MV, Cara Machado DC, Andrade MER, Cardoso VN, Dos Santos Martins F, Nicoli JR, Gomes MA.
    J Appl Microbiol; 2021 Jul 20; 131(1):460-469. PubMed ID: 33289232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.